The Law Offices of Frank R. Cruz Announces Investigation of Repro Med Systems, Inc. dba KORU Medical Systems (KRMD) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Repro Med Systems, Inc. dba KORU Medical Systems (“KORU Medical” or the “Company”) (NASDAQ: KRMD) on behalf of investors concerning the Company’s possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

On January 25, 2021, after the market closed, KORU Medical announced preliminary financial results for fiscal 2020 and expected full year revenue to be approximately $24.0 million, a 3.4% increase over the prior year results. The Company attributed the lower-than-expected results to, among other things, “[s]lower growth in net revenue as a result of strengthening our contractual position with large customers.” Moreover, KORU Medical’s Chief Executive Officer, Don Pettigrew, resigned, effective immediately.

On this news, the Company’s stock price fell $0.80, or 15.5%, to close at $4.33 per share on January 26, 2021.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased KORU Medical securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to [e-mail], or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.